ImmunoScape To Present at the 7th Annual CAR-TCR Summit San Diego, California and Singapore – September 14, 2022 – ImmunoScape, a pre-clinical biotechnology company focused on the discovery and development of next-generation TCR-T-cell therapeutics, today announced...
ImmunoScape Raises $14M to Facilitate the Discovery and Characterization of Cancer-Specific T-cell Receptors Anzu Partners led the $14M financing round with participation from Amgen Ventures and EDBI ImmunoScape’s Deep Immunomics and machine learning platforms...
Come see us at 7th Annual CAR-TCR Summit 9/19 – 9/23 in Boston, MA Dan MacLeod VP of Discovery Dan be presenting on “Discovery of TCRs targeting novel antigens using Deep Immunomics”.
